There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Until recently, the Centers of Medicare and Medicaid were restricted from negotiating
drug cost. We assessed the potential impact of alternative drug sourcing models on
Medicare Part D spending.